Allarity Therapeutics (ALLR) Expects Q4 EPS of $0.01—$0.04

Allarity ended Q3 with $24.1M in cash and restricted cash and expects Q4 earnings of $0.01—$0.04 per share. The release attributes the expected Q4 earnings primarily to a gain from settling a legacy liability.Material DetailsContext by AI AnalystThis is an early-stage clinical company reporting qua…